Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

NCT04668001 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04668001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04668001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 19, 2021
Completion date
September 1, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome